Review
Copyright ©The Author(s) 2025.
World J Stem Cells. Jun 26, 2025; 17(6): 107833
Published online Jun 26, 2025. doi: 10.4252/wjsc.v17.i6.107833
Table 2 Transplantation of mesenchymal stem cells in peripheral nerve injuries
Cell
Delivery
Models
Cell numbers
Outcome
Notes
Ref.
AT-MSCs (canine)PerineuralRat sciatic nerve crush1 × 106Improved electrophysiological and motor recoveryAssessment performed for 4 weeks[83]
AT-MSCs (rat)IntraperitonealRat sciatic nerve transection and suture repair2 × 106Improvement in nerve regeneration and functionalityNo difference was observed in compound muscle action potential latency between the saline and MSC groups[81]
BM-MSCs (rat)IM and IVSmall gap neurorrhaphy (rat sciatic nerve)1 × 106Improvements in the sciatic function index, nerve conduction velocity, and myelin sheath thicknessThe IM group showed better results compared with the IV group[80]
BM-MSCs (rat)IV and epineuralRat sciatic nerve transection and suture repairIV: 1 × 106. Epineural: 5 × 104Enhancement in the recovery rate of compound muscle action potential amplitudes and axon countsIV administration showed a more pronounced effect on electromotor recovery, while epineural injection was more effective in increasing fiber counts[82]
BM-MSCs (rat)Local injection and IVRat sciatic nerve transection/repair and individual nerve transection/repair5 × 106Improvements in motor function recovery in both modelsThe motor function recovery was significantly more pronounced in the individual nerve transection/repair model compared with the sciatic nerve transection/repair model[85]
BM-MSCs (rat)SubepineuralRat sciatic nerve transection and surgical coaptation5 × 105Improvements in the sciatic function indexThe group treated with MSCs and immunomodulators had better functional recovery than the group treated with MSCs alone. Immunomodulation using LPS and FK506 can improve MSC survival after transplantation[84]